Vagish Dwibedi Editor

Nadeem Akhtar was a Research Associate at the University of Guelph, Canada, where the objective of his work was to to improve companion animals' health in order to promote a superior and more health-conscious lifestyle. Prior to assuming this position, he worked as a postdoctoral researcher at the Department of Chemical Engineering, University of Waterloo, Canada (2019–2021), and the Department of Animal Biosciences, University of Guelph, Canada (2015–2019). Dr. Akhtar was awarded a Ph.D. from the Department of Biotechnology, Thapar Institute of Engineering and Technology, India.

Azamal Husen (MSc from Hamdard University, New Delhi, and PhD from Forest Research Institute, Dehra Dun, India) is a Foreign Delegate at Wolaita Sodo University, Wolaita, Ethiopia. He has served the University of Gondar, Ethiopia, as a Full Professor of Biology, and worked there as the Coordinator of the MSc Program and as the Head of the Department of Biology. He was a Visiting Faculty member of the Forest Research Institute, and the Doon College of Agriculture and Forest at Dehra Dun, India. He has more than 20 years’ experience of teaching, research, and administration. Dr Husen specializes in biogenic nanomaterial fabrication and application, plant responses to nanomaterials, plant adaptation to harsh environments at the physiological, biochemical, and molecular levels, herbal medicine, and clonal propagation for improvement of tree species. He has conducted several research projects sponsored by various funding agencies, including the World Bank, the Indian Council of Agriculture Research (ICAR), the Indian Council of Forest Research Education (ICFRE), and the Japan Bank for International Cooperation (JBIC).

Vagish Dwibedi did his B.Sc from Lucknow University, Lucknow, Uttar Pradesh, and Ph.D. from Thapar Institute of Engineering and Technology, Patiala, India. Dr. Dwibedi is an academician and researcher with more than eight years of experience in biotech research and development. He has carried out research projects and consultancy work in the areas of plant-microbe interaction/ bioassay-guided drug-discovery and development, food security/sustainable agriculture and waste water treatment. Presently he is working as Assistant Professor at University Institute of Biotechnology, Chandigarh University, Gharuan Mohali, Punjab. Formerly, he was worked as Research Scientist at Agpharm Bioinnovations LLP incubated at Thapar Institute of Engineering & Technology, Patiala, India. Dr. Dwibedi's work is directed towards the development of screening platforms for different biological activities such as anti-microbial, anti-oxidant, anti-cancer, or finding novel molecules that interfere in the mechanism of development of diseases such as Alzheimer Dementia (AD), Parkinson disease (PD), Obesity, Anti-gout (arthritis) and type 2 diabetes. He is also interested in food security, which predominantly involves the exploitation of plant-microbe interaction to combat abiotic stress and post-harvest preservation to enhance the shelf life of fresh crop/horticulture produces.

Santosh Kumar Rath is a medicinal and natural product chemist with more than 10 years of experience in research, academia, and industry. Dr. Rath received his doctorate from AcSIR at CSIR-Institute of Minerals and Materials Technology (CSIR-IMMT), Bhubaneswar, India. Presently he is working as Assistant Professor at Department of SoPPHI, Faculty of Pharmacy, DIT University, Dehradun, Uttarakhand, India. His areas of research are Natural Product Chemistry and Organic Synthesis, in which he has expertise in isolation, identification, and characterization of bioactive secondary metabolites, structural modification of major chemical constituents from plants as well as fungal sources. His research areas involve multistep synthesis of biologically active synthetic and/or natural product-based hybrid scaffolds for lead identification in special targets to neurological disease, cancer, HIV, Covid-19, and infectious diseases. His research is mainly focused on the synthesis of novel P-gp and bacterial efflux pump inhibitors, besides synthetic modifications of the bioactive natural products for better activity/minimize toxicity profiles. Currently, he is developing new synthetic methodologies for C-H functionalization of heterocycles and other medicinally relevant molecules.